Tag: candidates

Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; ...

Careernet, India's leading talent solutions provider, is set to organise their second edition of 'Career Fair for women', a virtual career fair through Careernet Prism, taking place from 11 am ...

OSAKA, Japan--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) today announced that its Board of Directors will propose two new candidates for independent external directors at the 146th Ordinary Meeting of Shareholders on June 29, ...

According to new research conducted by the Valuable 500, 47% of businesses believe there aren't enough candidates with a disability, however, research in the UK shows there are 1M disabled ...

Novel broad-spectrum oral lead candidates CDI-988 and CDI-873, discovered using Cocrystal’s antiviral drug discovery platform, demonstrate superior in vitro potency against SARS-CoV-2 and activity against all variants of concern including ...

New survey highlights trends and changes in tech work and recruiting in response to talent shortage; shows increase in hiring from non-academic backgrounds and mass recruiting for developer roles SAN ...

NEW YORK and SHANGHAI, Jan. 5, 2022 /PRNewswire/ -- Insilico Medicine, a global clinical-stage biotechnology company specializing in the applications of end-to-end artificial intelligence (AI) for drug discovery and development, today ...

CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron variant (B.1.1.529) based on structural analysis by X-ray crystallography ...

Nominees Would Ensure Lee Stockholders Have a Voice -- Management & Board Should Listen to Ownership Alden Reaffirms 30% Premium Offer to Acquire Lee for $24.00 per Share in Cash ...

BELTSVILLE, Md., Nov. 13, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, ...